What is the total value of India's pharmaceutical export to Hungary?

India exported pharmaceuticals worth $31.0M to Hungary across 442 verified shipments.

Who are the top Indian pharmaceutical exporters to Hungary?

1. CEVA SANTE ANIMALE — $25.0M. 2. HUMAN BIOPLAZMA MANUFACTURING AND TRADING LIMITED — $261.2K. 3. NEW LIFE BIOPHARMA LIMITED — $56.4K. Total: 29 suppliers.

Which companies in Hungary import pharmaceuticals from India?

1. CEVA POLCHEM PRIVATE LIMITED — $30.5M. 2. RELIANCE LIFE SCIENCES PRIVATE LIMITED — $261.2K. 3. MYLAN LABORATORIES LIMITED — $132.3K. 18 buyers total.

What pharmaceutical products does India export most to Hungary?

1. Vaccine ($30.5M, 98.3%); 2. Immunoglobulin ($261.2K, 0.8%); 3. Paclitaxel ($67.3K, 0.2%); 4. Dasatinib ($56.4K, 0.2%); 5. Metformin ($47.8K, 0.2%)

Why does Hungary import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $31.0M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Hungary?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Hungary pharmaceutical trade?

$70.2K per consignment across 442 shipments.

How many Indian pharmaceutical companies export to Hungary?

29 Indian companies. Largest: CEVA SANTE ANIMALE with $25.0M.

How can I find verified Indian pharmaceutical suppliers for Hungary?

TransData Nexus covers 29 active exporters with shipment history and trade values at transdatanexus.com.

Hungary to India Pharmaceutical Import (2026) — $31.0M, 29 Foreign Suppliers | TransData Nexus

Hungary to India Pharmaceutical Import (2026) — $31.0M, 29 Foreign Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — Hungary to India

#	Formulation	Value	Share
1	Vaccine	$30.5M	98.3%
2	Immunoglobulin	$261.2K	0.8%
3	Paclitaxel	$67.3K	0.2%
4	Dasatinib	$56.4K	0.2%
5	Metformin	$47.8K	0.2%
6	Amlodipine	$20.5K	0.1%
7	Tobramycin	$20.0K	0.1%
8	Pravastatin	$17.5K	0.1%
9	Telmisartan	$11.4K	0.0%
10	Valsartan	$4.7K	0.0%
11	Paracetamol	$4.5K	0.0%
12	Enalapril	$4.4K	0.0%
13	Moxifloxacin	$3.7K	0.0%
14	Atazanavir	$2.2K	0.0%
15	Ciprofloxacin	$2.0K	0.0%

India imports 20+ pharmaceutical formulations from Hungary with a combined trade value of $31.0M. Key products include Vaccine ($30.5M), Immunoglobulin ($261K), Paclitaxel ($67K), Dasatinib ($56K), Metformin ($48K). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 442 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — Hungary to India Trade Routes

1Vaccine$30.5M

2Immunoglobulin$261K

3Paclitaxel$67K

4Dasatinib$56K

5Metformin$48K

Top Hungary Suppliers to India

1Ceva Sante Animale

$25.0M

2Human Bioplazma Manufacturing And Trading Limited

$261K

3New Life Biopharma Limited

$56K

4Phoenix Pharma Zrt.

$48K

5Mylan Hungary Kft.

$45K

Trade Statistics

Total Value$31.0M

Shipments442

Indian Exporters29

Hungary Buyers18

Avg Shipment$70K

Products51

Other Import Origins

United States$2.7B Germany$929.2M China$767.5M Italy

Last updated: March 28, 2026

India–Hungary Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade corridor between Hungary and India has experienced notable growth from 2022 to 2026. In 2022, India's pharmaceutical imports from Hungary were valued at approximately $12.48 million, with a total of 442 shipments. By 2024, this figure had increased to $31.0 million, indicating a significant expansion in trade volume. This growth reflects the strengthening bilateral relations and the increasing demand for Hungarian pharmaceutical products in the Indian market.

Hungary's pharmaceutical exports to India are primarily composed of finished pharmaceutical formulations, including vaccines, immunoglobulins, and oncology drugs. The dominance of vaccines, accounting for 98.3% of the total import value, underscores Hungary's expertise and capacity in vaccine production. The presence of 29 Hungarian suppliers and 18 Indian buyers highlights a diversified and active trade network, facilitating the exchange of a wide range of pharmaceutical products.

2Hungary's Role in India's Pharma Imports

Hungary's contribution to India's pharmaceutical imports is significant, with a total import value of $31.0 million in 2024. This positions Hungary as a key supplier within the European Union, complementing other major exporters such as Germany and the Netherlands. The Hungarian pharmaceutical exports to India encompass a variety of products, with vaccines being the most prominent category. This specialization aligns with Hungary's strong pharmaceutical manufacturing capabilities and its strategic focus on high-quality, specialized products.

Hungary Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1CDSCO Registration Process

Hungarian pharmaceutical companies seeking to export finished pharmaceutical formulations to India must navigate the regulatory framework established by the Central Drugs Standard Control Organisation (CDSCO). The registration process involves submitting an application in Form 40 or Form 41, depending on the product category. These forms require comprehensive documentation, including product information, manufacturing details, and evidence of compliance with Good Manufacturing Practices (GMP). Clinical trial data may be waived for certain products, provided they are approved in Hungary and other recognized markets. The registration timeline can vary, but companies should anticipate a process that spans several months, contingent upon the completeness and accuracy of the submitted documentation.

2GMP & Manufacturing Standards

India mandates that all imported pharmaceutical products adhere to GMP standards as outlined by the World Health Organization (WHO). Hungarian manufacturing sites must demonstrate compliance with these standards, which are evaluated through CDSCO inspections. The inspection process assesses various aspects, including facility conditions, quality control measures, and adherence to manufacturing protocols. Manufacturers seeking WHO prequalification can enhance their credibility and facilitate smoother market entry, as this certification is recognized globally and often expedites the approval process in India.

3Import Documentation

To import pharmaceutical products into India, Hungarian companies must secure an Import License (Form 10) from the Directorate General of Foreign Trade (DGFT). Additionally, a Registration Certificate from the CDSCO is required, affirming that the product meets Indian regulatory standards. A No Objection Certificate (NOC) from the Ministry of Health and Family Welfare may also be necessary, depending on the product category. A Test License is required for each batch of imported products to ensure quality and safety. Customs procedures involve submitting these documents to Indian Customs authorities, along with payment of applicable duties and taxes, to facilitate the clearance of goods.

TransData Nexus Research · Hungary regulatory databasesMar 2026

Supply Chain & Logistics — India to Hungary Pharma Shipments

Shipping routes, port infrastructure, cold chain compliance

1Shipping Routes & Transit

Pharmaceutical products from Hungary to India are primarily transported via sea and air routes. Sea shipments typically involve transit through major European ports such as Hamburg or Rotterdam, followed by passage through the Suez Canal to Indian ports like Mumbai or Chennai. Air shipments are routed through international airports in Hungary, with direct flights to major Indian cities. Transit times vary, with sea shipments taking approximately 20-30 days and air shipments around 5-7 days, depending on the specific ports and logistics arrangements. The reliability of these routes is generally high, supported by established shipping lines and air cargo services.

2Port Infrastructure

Hungary's pharmaceutical exports are typically shipped from major ports such as the Port of Koper in Slovenia, which serves as a key gateway for Hungarian goods. In India, ports like Mumbai, Chennai, and Kolkata handle pharmaceutical imports. These ports are equipped with specialized facilities for handling pharmaceutical products, including temperature-controlled storage and dedicated customs procedures to ensure the integrity and compliance of imported goods.

3Indian Customs & Cold Chain

Upon arrival at Indian ports, pharmaceutical imports undergo customs clearance, which includes verification of import documentation, payment of applicable duties and taxes, and inspection by customs authorities. The Central Drugs Standard Control Organisation (CDSCO) conducts testing to ensure compliance with Indian pharmacopoeia standards. Cold chain management is critical for temperature-sensitive products like vaccines and biologics. Importers must ensure that products are transported and stored within specified temperature ranges to maintain efficacy. Compliance with Good Distribution Practices (GDP) is mandatory to ensure the quality and safety of pharmaceutical products throughout the supply chain.

TransData Nexus Research · DGFT port data, shipping intelligenceMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Hungary identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 442 verified shipments from 29 Indian exporters to 18 Hungary buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

29 Exporters

18 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

Hungary to India Pharmaceutical Import

Top Pharmaceutical Formulations — Hungary to India

Top Pharmaceutical Products — Hungary to India Trade Routes

Top Hungary Suppliers to India

Trade Statistics

Other Import Origins

India–Hungary Pharmaceutical Trade Corridor Analysis

1Trade Corridor Evolution

2Hungary's Role in India's Pharma Imports

Top Indian Buyers from Hungary

Product Routes

Full Dataset Access

3Recent Developments

Hungary Regulatory Landscape for Indian Pharmaceutical Exports

1CDSCO Registration Process

2GMP & Manufacturing Standards

3Import Documentation

Product Categories & Therapeutic Trends — India to Hungary

1Dominant Import Categories

2Innovation & Specialty Imports

3Import Demand Drivers

Trade Policy & Tariff Intelligence — India and Hungary

1India's Import Tariff Structure

2Trade Agreements & Preferences

3IP, Patents & Price Control